Physician profile
Kyle A Aldinger
NPI 1043203441
$752.99
in general payments reported to CMS, 2019-2025
9 companies · $91.43 in 2025
The $91.43 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.49 · 2020: $91.77 · 2021: $102 · 2022: $142 · 2023: $103 · 2024: $170 · 2025: $91.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $265.59 | 2021-2025 | Qulipta |
| Novo Nordisk INC | $159.53 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $100.65 | 2019-2023 | Farxiga |
| Pfizer INC. | $71.24 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $45.35 | 2020 | |
| Glaxosmithkline, LLC. | $31.09 | 2024-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $29.47 | 2022-2023 | Trintellix |
| Biohaven Pharmaceuticals, INC. | $29.37 | 2020-2021 | |
| Dexcom, INC. | $20.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Aldinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.